200 likes | 337 Views
Alliance for Cellular Signaling (AfCS). “Scaling up” academic science. Collaboratory types. Distributed research center Large-scale, high-throughput academic/ industry hybrid Community data system Unique model for motivating and coordinating community contributions. History.
E N D
Alliance for Cellular Signaling(AfCS) “Scaling up” academic science
Collaboratory types • Distributed research center • Large-scale, high-throughput academic/ industry hybrid • Community data system • Unique model for motivating and coordinating community contributions
History • Success of human genome project • NIH budget increase led to “Glue Grant” idea- scaling up science • AfCS was the first glue grant, several others have followed
History • Al Gilman organized two meetings of signalling community at UTSW • Meeting #1: ~12 people from UTSW • Meeting #2 ~ 30 people • Funded started in 2000
Scientific problem • AfCS is an attempt to account for all signalling activity in a few model cells
Scientific problem • There are ~3,000 molecules that are potential ‘signals’ in a cell • Interactions are complex and poorly understood • “How do cells hear and interpret one voice when 50 are shouting (or mumbling)?”
Distribution of funded participants Barbraham, UK University of Washington Harvard BC Signaling Assays Lab Berkeley JHU UCSF Stanford Microscopy Lab Cal Tech Salk Nashville UCSD Molecular Biology Lab Bioinformatics Lab UT Southwestern Protein Lab Antibody Lab Cellular Preparation Steering Committee Systems Committee Lymphocyte Systems Committee Myocyte Alliance Labs
80% Technology Dev. Committee System Committees 40%100% 10% 5-10% Bridging Projects Organization from Gilman, 2003 Steering Committee Labs/Resources Administration Bioinformatics, data dissemination Membership & Editorial Committee Cell prep & analysis Assay development Editorial board Molecular biology Proteins Antibodies Alliance members Microscopy Signaling research community Signaling database
Products- Alliance Labs • High quality data repository for the field- produced by labs • IP policy dictates that data is open to everyone • AfCS labs (informally) excluded! • Alliance members expected to do publishable analysis of this data
Products- outside Alliance members • Signalling Gateway • Co-published with Nature Publishing Group • Molecule pages-- 3,000 article reference on every relevant molecule in the virtual cell • Outside researchers recruited to write Molecule pages- equivalent to a journal review article
Technology used • Email lists • Custom bioinformatics databases • Developed at UCSD • Polycom • Use application sharing • Supported by UTSW • Reports • Annual meeting • Newsletters • Website • Web boards
Use of Polycom • All PI’s have Viewstations in their offices • Gilman uses as a replacement for the phone • Used for all multi-site meetings, along with shared slides
Motivations of participants • Dis-incentives to be overcome: • No ownership of data- IP policy dictated immediate publication • Little publication opportunity • Little distribution of individual credit
Motivations of participants • Professional bench staff • Experience useful in industry or med school • “Best of both worlds” academic and corporate • Research staff - Lab directors, committee members • Chance to be involved in an innovative project • Lab improvement • Idiosyncratic motivations
Motivations- community data system contributors • Molecule pages are equivalent to a review article, but more structured and need to be updated yearly • Co-published by Nature Publishing Group • (Will these ‘count’ as academic publications?)
Alliance successes to date • IP policy • Recruitment of participants, members • Signalling gateway and ‘mini’ molecule pages • Standardizing protocols • Bioinformatics infrastructure • Public antibody database, reagents, protocols
Protocols • Improvements in protocols due to need for replication
Challenges • Specific target molecules being changed both to avoid problems and take advantage of new technology • Aggregation of data yet to be attempted • Relationship with outside authors still untested
Outstanding questions: • Will academic/ industry hybrid model be successful? • Will CDS model (Molecule pages) be successful? • Will other Glue grant projects succeed in similar projects with radically different organizational structures?